Dr. Zeid Mohamedali is an active consulting urological surgeon at several hospitals in British

Columbia, Canada with over 20 years of experience in medical research and clinical practice

specializing in pain management, oncology and urological diseases.

A Fellow of the Royal College of Physicians and Surgeons, Zeid is board certified in Urology by the

Medical Council of Canada (FRCSC). He received his MD and PhD degrees from the Faculty of

Medicine at the University of British Columbia. He has been certified in physician leadership under the Sauder School of Business leadership MBA program. Zeid hold a position as a Clinical Assistant

Professor in the department of Urological Sciences, UBC. He has authored a number basic

science papers in peer-reviewed journals in the topic of aging and cancer, cancer detection

methods, and cell biology processes. He holds 3 patents for medical devices in healthcare and

continues to work on newer devices for pain management in patients.

He has been a medical Director of Urodynamix Inc, Protox Therapeutics, Kalgene,

Bench2Benside Research Inc, and Vancouver Skin Rejuvenation Centers. Dr. Mohamedali

serves as a medical or scientific advisor to several pharmaceutical companies including Pfizer,

Astellas Pharma, J&J (Janssen), Abbvie Corp, Astrazeneca, TerSera Canada, Amgen, Cook

Medical, Bayer, Lilly, and Allergan. He has received numerous awards and honours for his

research from the American Urological Association, Canadian Cancer Society, Natural

Sciences and Engineering Research Council of Canada and Medical Research Council of

Canada.

Dr. Mohamedali has been involved in several phase 3 and 4 clinical trials in novel cosmetic

procedures. He has an extensive history of medical and cosmetic Botox use and was involved

in pivotal trials for Botox and Bladder dysfunction. Drawing from his surgical practice, he has

perfected a number of unique injection techniques for cosmetic fillers and Botox.

Dr. Mohamedali has over 8 years of Medical Cannabis pain management. He has a large

practice of patients with chronic pain, insomnia, anxiety, gastrointestinal disease, and other

ailments. Previously, Zeid was the CEO for Greenleaf Medical Clinics, clinics dedicated to

providing high quality medical cannabis care for patients with various ailments requiring

cannabis treatment. He continues to be an active clinician in cannabis medicine. He is

currently involved in cannabis research for migraines and pelvic pain; he is also an

investigator in a phase 4 clinical trial in narcotic and benzodiazepine reduction using

cannabis.

Dr. Mohamedali recently was the Chief Medical Officer for Zenabis Global and its European

partner, Zenpharm . Dr. Mohamedali, his grad students, and his research team are responsible

for several basic science research projects, clinical trials, education, and policy reviews for

medical use of cannabis. Dr. Mohamedali continues to participate in shaping European and UK

medical cannabis policies. Most recently he has been leading the international launch of

SeedCertin, a blockchain platform delivering medical cannabis and psychedelic medicine

research.

With his expertise in many areas of Medical Aesthetics and being one of the only injectors on Vancouver Island to perfect the cannula application technique, he is able to insure that patients seeking rejuvenation of their look will be completely satisfied and will look natural and refreshed being able to chose from a wide variety of advanced injection techniques and products.